4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 0.445 AUD -2.2% Market Closed
Market Cap: 183m AUD
Have any thoughts about
4DMedical Ltd?
Write Note

Net Margin
4DMedical Ltd

-958.3%
Current
-4 557%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-958.3%
=
Net Income
-36m
/
Revenue
3.8m

Net Margin Across Competitors

Country AU
Market Cap 186.7m AUD
Net Margin
-958%
Country US
Market Cap 36.5B USD
Net Margin
25%
Country US
Market Cap 31.3B USD
Net Margin
10%
Country AU
Market Cap 26.1B AUD
Net Margin
50%
Country US
Market Cap 10.9B USD
Net Margin
34%
Country US
Market Cap 6.4B USD
Net Margin
-6%
Country JP
Market Cap 934B JPY
Net Margin
16%
Country US
Market Cap 5.6B USD
Net Margin
4%
Country SE
Market Cap 53.2B SEK
Net Margin
25%
Country US
Market Cap 2.4B EUR
Net Margin
-4%
Country CN
Market Cap 16.2B CNY
Net Margin
11%
No Stocks Found

4DMedical Ltd
Glance View

Market Cap
182.6m AUD
Industry
Health Care

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX Intrinsic Value
0.467 AUD
Undervaluation 5%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-958.3%
=
Net Income
-36m
/
Revenue
3.8m
What is the Net Margin of 4DMedical Ltd?

Based on 4DMedical Ltd's most recent financial statements, the company has Net Margin of -958.3%.